These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21446933)

  • 21. Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol.
    Aramaki T; Sekiyama T; Katsuta Y; Kurokawa H; Komeichi H; Tsutsui H; Terada H; Ohsuga M; Satomura K; Okumura H
    J Hepatol; 1992 May; 15(1-2):48-53. PubMed ID: 1354676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rheohepatographic assessment of the therapeutic effects of propranolol on portal hypertension].
    Wu XN
    Zhonghua Yi Xue Za Zhi; 1985 Jul; 65(7):411-3, 446. PubMed ID: 3938325
    [No Abstract]   [Full Text] [Related]  

  • 23. Long term effects of propranolol on portal pressure in cirrhotic patients.
    Orban-Schiopu AM; Popescu CR
    Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
    Bondarenko IP; Dubinskiĭ AA; Tereshkin IG
    Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of compound Salvia pill combined with propanolol on liver fibrosis and portal hypertension].
    Liang YG; Chu XJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 May; 22(5):382-3. PubMed ID: 12584844
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of propranolol on portal vein hemodynamics in patients with liver cirrhosis: assessment by duplex sonography.
    Zoller WG; Wagner DR; Zentner J
    Z Gastroenterol; 1993; 31(7-8):425-8. PubMed ID: 8379228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Per-rectal scintigraphy of the portal system with pertechnetate TC-99M: effect of propranolol on portosystemic collateral circulation in patients with cirrhosis. Part II].
    Bołdys H; Hartleb M; Rudzki K; Nowak A; Nowak S
    Pol Arch Med Wewn; 1994 Jul; 92(1):19-25. PubMed ID: 7971473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propranolol stereoisomer plasma concentrations and portal haemodynamic response in patients with liver cirrhosis.
    Schepke M; Raab P; Hoppe A; Brensing K; Paar D; Potyka U; Sauerbruch T
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1451-8. PubMed ID: 10571601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vasodilators and renal function in cirrhosis].
    Albillos A; Iborra J
    Gastroenterol Hepatol; 1995 Nov; 18(9):488-92. PubMed ID: 8521230
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of the effects of molsidomine and propranolol-molsidomine combination on portal hemodynamics by pulsed Doppler ultrasound].
    Monnin JL; Vinel JP; Le Quellec A; Pascal JP; Taourel P; Bruel JM; Blanc F; Michel H; Ciurana AJ
    Gastroenterol Clin Biol; 1992; 16(10):745-50. PubMed ID: 1478400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasodilator therapy of portal hypertension: focus on the liver.
    Blei AF
    Hepatology; 1989 Jun; 9(6):896-9. PubMed ID: 2653996
    [No Abstract]   [Full Text] [Related]  

  • 32. Portal venous flow in response to acute beta-blocker and vasodilatatory treatment in patients with liver cirrhosis.
    Zoli M; Marchesini G; Brunori A; Cordiani MR; Pisi E
    Hepatology; 1986; 6(6):1248-51. PubMed ID: 2878867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined use of propranolol and nifedipine offers better effects on portal vein nonuniform remodeling in carbon tetrachloride (CCl(4))-induced portal hypertensive rats.
    Zhang ZQ; Shi B; Wu GQ; Qin KR; Jiang ZL; Zhu L
    Eur J Pharmacol; 2009 Jun; 613(1-3):108-13. PubMed ID: 19401196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does losartan work after all?
    Blendis LM; Wong F
    Am J Gastroenterol; 2003 Jun; 98(6):1222-4. PubMed ID: 12818261
    [No Abstract]   [Full Text] [Related]  

  • 35. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
    Abraldes JG; Tarantino I; Turnes J; Garcia-Pagan JC; Rodés J; Bosch J
    Hepatology; 2003 Apr; 37(4):902-8. PubMed ID: 12668985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.
    Morillas RM; Planas R; Cabré E; Galán A; Quer JC; Feu F; García Pagán JC; Bosch J; Gassull MA
    Hepatology; 1994 Dec; 20(6):1502-8. PubMed ID: 7982651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propranolol and portal hypertension in cirrhosis.
    Wilkinson RP
    Lancet; 1980 Aug; 2(8191):429. PubMed ID: 6105550
    [No Abstract]   [Full Text] [Related]  

  • 38. Haemodynamic effects of combined treatment with molsidomine and propranolol on portal hypertension in conscious and unrestrained cirrhotic rats.
    Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
    J Gastroenterol Hepatol; 1996 Oct; 11(10):985-92. PubMed ID: 8912139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic effect of spironolactone in liver cirrhosis and propranolol-resistant portal hypertension.
    Sen S; De BK; Biswas PK; Biswas J; Das D; Maity AK
    Indian J Gastroenterol; 2002; 21(4):145-8. PubMed ID: 12385542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemodynamic and renal effects of tadalafil in patients with cirrhosis.
    Kalambokis GN; Kosta P; Pappas K; Tsianos EV
    World J Gastroenterol; 2010 Oct; 16(39):5009-10. PubMed ID: 20954291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.